- Investing Ideas
- Chinese Pharmaceuticals & Biotech Healthy high growth potential
Chinese Pharmaceuticals & Biotech Healthy high growth potential
Results
7
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
7 companies
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥27.4b
A commercial-stage biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of oncology and hematologic disorders.
688192
CN¥59.00
7D
-3.1%
1Y
-29.2%
PharmaResources (Shanghai)
Market Cap: CN¥6.4b
Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.
301230
CN¥35.72
7D
-7.4%
1Y
17.6%
PharmaBlock Sciences (Nanjing)
Market Cap: CN¥12.0b
Provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally.
300725
CN¥51.46
7D
-6.0%
1Y
11.4%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥9.5b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥25.95
7D
-1.6%
1Y
-22.4%
AcrobiosystemsLtd
Market Cap: CN¥16.5b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥98.92
7D
9.7%
1Y
71.1%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥8.4b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥15.44
7D
-3.1%
1Y
-1.2%
Inner Mongolia Furui Medical Science
Market Cap: CN¥11.0b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥41.67
7D
-7.4%
1Y
-35.2%